TMED vs. PSIL
TMED (T. Rowe Price Health Care ETF) and PSIL (AdvisorShares Psychedelics ETF) are both Health & Biotech Equities funds. At a 0.43 correlation, their price movements are largely independent. TMED charges 0.44%/yr vs 1.00%/yr for PSIL.
Performance
TMED vs. PSIL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TMED achieves a 3.87% return, which is significantly lower than PSIL's 21.37% return.
TMED
- 1D
- 1.04%
- 1M
- 2.47%
- YTD
- 3.87%
- 6M
- 4.17%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PSIL
- 1D
- 1.01%
- 1M
- 2.50%
- YTD
- 21.37%
- 6M
- 20.94%
- 1Y
- 68.63%
- 3Y*
- 9.89%
- 5Y*
- —
- 10Y*
- —
TMED vs. PSIL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 3.87% | 18.92% |
PSIL AdvisorShares Psychedelics ETF | 21.37% | 34.86% |
Correlation
The correlation between TMED and PSIL is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 13, 2025 | 0.43 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. PSIL — Risk / Return Rank
TMED
PSIL
TMED vs. PSIL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and AdvisorShares Psychedelics ETF (PSIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| TMED | PSIL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 1.65 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.35 | -0.41 | +1.77 |
Drawdowns
TMED vs. PSIL - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, smaller than the maximum PSIL drawdown of -92.72%. Use the drawdown chart below to compare losses from any high point for TMED and PSIL.
Loading charts...
Drawdown Indicators
| TMED | PSIL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | -92.72% | +81.61% |
Max Drawdown (1Y)Largest decline over 1 year | — | -20.38% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -64.62% | — |
Current DrawdownCurrent decline from peak | -2.75% | -76.39% | +73.64% |
Average DrawdownAverage peak-to-trough decline | -2.59% | -76.76% | +74.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 9.64% | — |
Volatility
TMED vs. PSIL - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | PSIL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 9.80% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 27.73% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.04% | 41.78% | -23.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.04% | 63.13% | -45.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.04% | 63.13% | -45.09% |
TMED vs. PSIL - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is lower than PSIL's 1.00% expense ratio.
Dividends
TMED vs. PSIL - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.52%, less than PSIL's 8.23% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
PSIL AdvisorShares Psychedelics ETF | 8.23% | 10.95% | 1.49% | 0.24% | 2.91% |
TMED T. Rowe Price Health Care ETF | 0.52% | 0.54% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TMED and PSIL have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TMED is cheaper with a 0.44% expense ratio, compared with 1.00% for PSIL.
PSIL has the higher dividend yield at 8.23%, compared with 0.52% for TMED.
They also come from different issuers: T. Rowe Price and AdvisorShares. Their fees differ too: 0.44% for TMED and 1.00% for PSIL.
Find the right allocation for TMED and PSIL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer